Cloned (Comment) | Organism |
---|---|
alpha-sarcin cDNA cloned by consecutive annealing of overlapping primers followed by ligation into XhoI- and HindIII-sites in pcDNA3.1 or pcDNA3-mychis vector (C-terminal MycHis tag). alpha-Sarcin cDNA cloned into 3 × FLAG pMSCV to obtain a N-terminal 3 × Flag tagged version of alpha-sarcin. Expression of wild-type and mutant constructs in HeLa or Cos-7 cells | Aspergillus giganteus |
Protein Variants | Comment | Organism |
---|---|---|
H137Q | similar to the wild-type and mutant R121Q, this mutant is cytotoxic in HeLa cells or Cos-7 cells in a dose-dependent manner. Both GFP and luciferase expression are not inhibited | Aspergillus giganteus |
R121Q | despite its reduced catalytic ability in vitro, the mutant is cytotoxic in HeLa cells or Cos-7 cells in a dose-dependent manner, that is only slightly reduced from that observed for wild-type. Both GFP and luciferase expression are not inhibited | Aspergillus giganteus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | both mutant and wild-type variants of alpha-sarcin localize to the nucleus and cytoplasm, where they colocalize with ribosomal marker RPS6 | Aspergillus giganteus | 5737 | - |
nucleus | both mutant and wild-type variants of alpha-sarcin localize to the nucleus and cytoplasm, where they colocalize with ribosomal marker RPS6 | Aspergillus giganteus | 5634 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Aspergillus giganteus | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
alpha-sarcin | - |
Aspergillus giganteus |
General Information | Comment | Organism |
---|---|---|
malfunction | mutations in alpha-sarcin, which impair alpha-sarcin's ability to inhibit protein synthesis, do not affect its cytotoxicity. The mutants are unable to activate Jun N-terminal kinase, thus the sarcin-ricin loop remains intact indicating that the alpha-sarcin mutants are catalytically inactive | Aspergillus giganteus |
physiological function | both alpha-sarcin and ricin transfected cells demonstrate a dose-dependent decrease in viability at 48 hours, whereby ricin is more effective at low doses (50 ng) than alpha-sarcin. At concentrations greater than 250 ng, no further reduction in viability and approximately 20% of the cells remain viable. Direct cytoplasmic expression of alpha-sarcin and ricin in mammalian cells is cytotoxic: exogenous expression of both alpha-sarcin and ricin in HeLa cells results in decreased viability within 48 hours. Both alpha-sarcin and ricin induce cell death at similar rates, with ricin exhibiting slightly enhanced cytotoxicity. Direct expression of alpha-sarcin in Cos-7 cells also results in cytotoxicity. Although protein synthesis inhibition likely contributes to cell death, it is not required. alpha-Sarcin can promote cell death through a mechanism that is independent of rRNA cleavage and Jun N-terminal kinase activation | Aspergillus giganteus |